Regulatory and Clinical Trials for Therapeutics

Dr Whitley, FDA, on Clinical Trials

GSK Plans Phase III Clinical Trial for Hepatitis B | bepirovirsen Clinical Trial Phase 3

Webinar — Comparing CTA Submission (EMA/Health Canada) to IND Applications (FDA) for Phase I Trials

Regulatory Authority Inspections in Clinical Trials - FDA and MHRA - Part 3

Unveiling The Responsibilities of FDA In Clinical Trials : Behind The Scenes💊👨‍⚕️🔥🩺#clinicalresearch

FDA-MHRA-HC 2024 Joint Symposium (Day 3)

PH FDA studying Sinovac's phase 3 clinical trial results, Moderna to present vaccine findings| ANC

The New Landscape | Patient Summit Seminar with Dr. Wadhwani

Worried about Your Next FDA Meeting? Key Tips to Make It a Success

FDA Webinar on the Infant Formula Transition Plan for Exercise of Enforcement Discretion (Part 1)

Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018

FDA Clinical Investigator Training Course (CITC) 2022, Day 1 – Part 3

FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy

Diversity in Clinical Trials: Learn about Enrollment Trends and Resources from FDA

FDA meetings Drug Development process | Regulatory affairs |

MDA Engage Webinar Clinical Trials: From Design to FDA Consideration

FDA Clinical Investigator Training Course (CITC) 2023, Day 1 – Part 3

Lecture 3 - FDA Drug Approval 101- Reading and Interpreting Cancer Trials Series

Drug Discovery: The Pathway to FDA Approval